Safety and tolerability of Rinvecalinase Alfa (DM199) for acute ischemic stroke (ReMEDy1)
Bruce Campbell(The Royal Melbourne Hospital), Helen M. Dewey(Eastern Health), Scott E. Kasner(University of Pennsylvania), Geoffrey Cloud(Monash University), Annette Lista(Hennepin County Library), Ramesh Sahathevan(St Vincent's Hospital Melbourne), Tissa Wijeratne(Sunshine Hospital), Timothy Kleinig(Royal Adelaide Hospital), Philip Choi, Carlos García-Esperón, Andrew Wong(MACOM (United States)), Philip M. Bath(Nottingham University Hospitals NHS Trust), Dennis Cordato(Liverpool Hospital), Michael Giuffre(University of Calgary), Darshan Ghia(Fiona Stanley Hospital), John Volpi(Houston Methodist)
Cited by 3
Related Papers
Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials
|The Lancet|2016|7.6k
Endovascular Therapy for Ischemic Stroke with Perfusion-Imaging Selection
|New England Journal of Medicine|2015|5.8k
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
|Stroke|2014|5.2k
An Updated Definition of Stroke for the 21st Century
|Stroke|2013|3.5k